Latest news with #BLU-UBlueLightPhotodynamicTherapy
Time of India
19-05-2025
- Business
- Time of India
Sun Pharma shares in focus after USFDA nod for next-gen skin disorder device
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Shares of Sun Pharmaceutical Industries are set to be in focus on Monday after the company announced that it had received approval from the U.S Food and Drug Administration (USFDA) for its next-generation BLU-U Blue Light Photodynamic Therapy (PDT) device, developed for the treatment of actinic keratosis—a precancerous skin a stock exchange filing on Friday, Sun Pharma said the USFDA had approved its upgraded PDT system under the agency's Real-Time Review Program. The device treats actinic keratoses, or AKs, in combination with LEVULAN® KERASTICK®—a liquid containing aminolevulinic acid that is used to target minimally to moderately thick lesions on the face, scalp, and upper to the U.S. National Center for Biotechnology Information (NCBI), actinic keratosis is often associated with chronic sun exposure, (and) individuals with actinic keratosis may present with irregular, red, scaly papules or plaques on sun-exposed regions of the body. The condition can progress to skin cancer if left Pharma's upgraded BLU-U device replaces the older fluorescent-tube-based model with modern LED technology, making it 'more compact and easier to use,' the company said.'We are pleased to receive the FDA's approval of LED BLU-U and look forward to seeing the positive impact this next generation device will have for those living with actinic keratosis,' said Abhay Gandhi, chief executive officer at Sun Pharma (North America).'As a company committed to innovation, we are confident that this new LED BLU-U model will provide improved efficiency and reliability while maintaining the safety and efficacy that healthcare professionals and people with AKs have come to trust from Sun Pharma,' Gandhi company's stock has gained 13% over the past year and 2% in the past three months, though it declined 0.6% over the last the technical front, Sun Pharma shares are currently trading below six of their eight key simple moving averages, including the 10-day, 20-day, 30-day, 100-day, 150-day, and 200-day SMAs. The 14-day Relative Strength Index (RSI) stands at 47.7, suggesting a neutral trend.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
India Today
19-05-2025
- Business
- India Today
Stocks to watch on May 19: Bajaj Auto, Delhivery, Dr Reddy's, JSW Steel, BEL
Markets ended lower on Friday, even though they had seen a strong rally earlier in the week. After gaining more than 4% during the week and breaking a three-week consolidation, investors booked profits on the last trading day due to the absence of any major new trigger. Despite hopes of interest rate cuts, strong economic data, and talks of a trade deal with the US, the market could not hold on to its the market opens on May 19, many companies will be in focus due to their earnings and key updates, such as Power Grid Corporation of India, Bharat Electronics, DLF, ACME Solar Holdings, Bajaj Auto, Delhivery, Dr Reddy's, JSW Steel, etc. Here are the major stocks to keep an eye on:Q4 RESULTS TODAYThe following companies are expected to announce their quarterly results on May 19:Power Grid Corporation of India, Bharat Electronics, DLF, ACME Solar Holdings, CMS Info Systems, DOMS Industries, Gujarat Gas, HEG, IRB Infrastructure Developers, JK Paper, One Mobikwik Systems, NLC India, Petronet LNG, Pfizer, PI Industries, Quess Corp, Sun Pharma Advanced Research Company, and Zydus AUTOBajaj Auto's international arm, Bajaj Auto International Holdings BV, has signed loan agreements with JP Morgan Chase Bank NA, DBS Bank, and Citigroup Global Markets Asia. The loan amount is 566 million euros (Rs 5,431.08 crore). It is an unsecured loan with a one-year REDDY'S LABORATORIESThe US health regulator, USFDA, completed an inspection of Dr Reddy's API facility in Middleburgh, New York. The inspection took place from May 12 to May 16. The USFDA issued a Form 483 with two LABORATORIESDivis reported a 23% year-on-year (YoY) rise in net profit to Rs 662 crore for the March 2025 quarter. Its revenue rose by 12.2% YoY to Rs 2,585 crore. The board has declared a dividend of Rs 30 per ELECTRONICS (BEL)BEL has received additional orders worth Rs 572 crore since April 7. The orders include Integrated Drone Detection and Interdiction Systems, Software Defined Radios, communication units for weapons, AI-based naval solutions, simulators, jammers, spares, and related PHARMACEUTICAL INDUSTRIESThe USFDA has approved Sun Pharma's updated version of the BLU-U Blue Light Photodynamic Therapy device. The new device uses LED panels instead of the earlier fluorescent STEELJSW Steel's board will meet on May 23 to discuss long-term fundraising and the possibility of declaring a ENERGIESPremier Energies reported a 167.2% YoY jump in net profit to Rs 277.8 crore. Revenue rose by 43.9% YoY to Rs 1,620.8 crore in Q4FY25. The company also signed two joint venture agreements — one with Nuevosol Energy for aluminium frame manufacturing and another with Sino-American Silicon Products turned profitable in the fourth quarter ended March 2025, reporting a net profit of Rs 72.6 crore. Revenue rose by 5.6% YoY to Rs 2,191.6 INTERNATIONALKEC International has received new orders worth Rs 1,133 crore for transmission and distribution projects within HEALTHCARE INSTITUTEMax Healthcare's arm Crosslay Remedies has bought a 4,000-square-metre land parcel next to Max Super Speciality Hospital, Vaishali, for Rs 120 crore. The new space will allow the hospital to add 140 beds in the next 30 (INDIA)NBCC has sold 446 residential units at Aspire Silicon City, Noida, through an e-auction for a total sale value of Rs 1,467.93 crore. The company will earn a 1% marketing TECHNOLOGIESZen Technologies posted a 189.2% YoY rise in net profit to Rs 101 crore, with revenue jumping 129.8% YoY to Rs 325 crore in Q4FY25. Ebitda went up by 175% to Rs 138 crore. The company also declared a dividend of Rs 2 per INFRATECHPNC Infratech received an arbitration award worth Rs 485.28 crore along with 12% annual interest. The case was related to the construction of the Agra Bypass in Uttar Pradesh under PROJECTS INTERNATIONALKalpataru reported a 37.2% YoY rise in net profit to Rs 225.4 crore. Revenue increased by 18.3% YoY to Rs 7,066.8 crore in Q4FY25. The board has announced a final dividend of Rs 9 per share for the financial PHARMACEUTICALSGSK Pharma has reported a fire incident at one of its contract manufacturing sites. Production has been disrupted temporarily, and the company is reviewing the impact and working to resume GRAMEENThe company reported a sharp 88.1% YoY fall in net profit to Rs 47.2 crore. Net interest income fell slightly to Rs 876.5 crore. Impairments on financial instruments rose nearly four times to Rs 582.9 AUTO TECHNOLOGIESLumax Auto's board has approved buying the remaining 25% stake in IAC International Automobile India for Rs 221 crore. After the deal, IAC International will become a fully owned subsidiary of the ALKALIES AND CHEMICALSThe company returned to profit with a net profit of Rs 8.8 crore for the quarter. Revenue rose 7.4% YoY to Rs 1,075.5 crore. The board has recommended a dividend of Rs 15.80 per share. advertisement
